Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2019-07-01 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LILLE (59000), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE SEBASTOPOL : revenue, balance sheet and financial ratios
PHARMACIE SEBASTOPOL is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LILLE (59000),
this company of category PME
shows in 2023 a net income positive of 6 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SEBASTOPOL (SIREN 851985119)
Indicator
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
5 777 €
129 403 €
242 847 €
196 956 €
25 332 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE SEBASTOPOL generates positive net income of 6 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2023: 25 k€ -> 6 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
5 777 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -1764%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-1764.267%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-5.198%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
Debt ratio
902.423
332.065
181.49
125.543
-1764.267
Financial autonomy
8.479
19.574
28.399
35.718
-5.198
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
-1764.272023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent-44 pts over 3 years
In 2023, the debt ratio of PHARMACIE SEBASTOPOL (-1764.27) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-5.2%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE SEBASTOPOL (-5.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 271.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
Liquidity ratio
190.177
252.449
238.379
237.46
271.291
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
271.292023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Excellent+8 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE SEBASTOPOL (271.29) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE SEBASTOPOL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE SEBASTOPOL is estimated at
68 165 €
(range 41 454€ - 95 825€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
41k€68k€95k€
68 165 €Range: 41 454€ - 95 825€
NAF 5 année 2023
Valuation method used
Net Income Multiple
5 777 €
×
11.8x
=68 166 €
Range: 41 455€ - 95 825€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SEBASTOPOL with other companies in the same sector:
Frequently asked questions about PHARMACIE SEBASTOPOL
What is the revenue of PHARMACIE SEBASTOPOL ?
The revenue of PHARMACIE SEBASTOPOL is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE SEBASTOPOL profitable?
Yes, PHARMACIE SEBASTOPOL generated a net profit of 6 k€ in 2023.
Where is the headquarters of PHARMACIE SEBASTOPOL ?
The headquarters of PHARMACIE SEBASTOPOL is located in LILLE (59000), in the department Nord.
Where to find the tax return of PHARMACIE SEBASTOPOL ?
The tax return of PHARMACIE SEBASTOPOL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SEBASTOPOL operate?
PHARMACIE SEBASTOPOL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart